an obesity expert at the University of Washington and one of the 58 authors of the report published in The Lancet Diabetes & Endocrinology journal.The report introduces two new diagnostic ...
T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...
The extent to which newer, incretin-based drugs for obesity improve disease outcomes via weight loss versus the direct ...
The commission recommends a shift away from relying solely on BMI to more accurately define obesity as a disease.
The benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an ...